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Abstract
Background: Rapid progress in the field of gene expression-based molecular network integration
has generated strong demand on enhancing the sensitivity and data accuracy of experimental
systems. To meet the need, a high-throughput gene profiling system of high specificity and
sensitivity has been developed.
Results: By using specially designed primers, the new system amplifies sequences in neighboring
exons separated by big introns so that mRNA sequences may be effectively discriminated from
other highly related sequences including their genes, unprocessed transcripts, pseudogenes and
pseudogene transcripts. Probes used for microarray detection consist of sequences in the two
neighboring exons amplified by the primers. In conjunction with a newly developed high-throughput
multiplex amplification system and highly simplified experimental procedures, the system can be
used to analyze >1,000 mRNA species in a single assay. It may also be used for gene expression
profiling of very few (n = 100) or single cells. Highly reproducible results were obtained from
duplicate samples with the same number of cells, and from those with a small number (100) and a
large number (10,000) of cells. The specificity of the system was demonstrated by comparing
results from a breast cancer cell line, MCF-7, and an ovarian cancer cell line, NCI/ADR-RES, and
by using genomic DNA as starting material.
Conclusion: Our approach may greatly facilitate the analysis of combinatorial expression of
known genes in many important applications, especially when the amount of RNA is limited.
Background
Biological processes are underlain by interactions
between various genes and their products through defined
pathways in the molecular network, in which molecules
cross communicate in hitherto unknown ways under both
healthy and disease conditions. Learning gene expression
patterns on a genomic scale would substantially help
deconvolute these complex processes. Exhaustive identifi-
cation of human genes during the Human Genome
Project has made such studies possible. By global gene
expression profiling in cells and tissues under either phys-
iological or in vitro conditions, our understanding of the
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correlation between gene functions and their phenotypic
effects could be significantly enhanced.
The advent of the microarray-based high-throughput RNA
detection system [1,2] has made it possible to profile gene
expression patterns for the entire transcriptome. However,
to detect gene transcripts very specifically, one needs to
discriminate them from closely related sequences includ-
ing: (1) the corresponding gene sequences. Although con-
tamination of gene sequences may not be a concern for
applications using purified mRNA, gene sequences must
be taken into consideration for applications directly using
cell lysate without RNA extraction. This becomes espe-
cially important when the studied transcripts are present
at low abundance; (2) pseudogenes and their possible
transcripts. The number of pseudogenes in the human
genome was estimated to be 20,000 to 33,000, which are
widely expressed [3,4]. These sequences usually share a
high degree of sequence identity with the closely related
genes; (3) unprocessed RNA containing the same exons as
those of the corresponding mRNA. So far, no system has
addressed the above issue very effectively.
Among the microarray-based platforms, GeneChip is a
commonly used system and has been improved signifi-
cantly since it was invented, and has contributed to under-
standing the complex gene expression network in a great
deal. However, since this technology is limited by its high
degree of nonspecificity and insensitivity, its application
has been limited in molecular network integration.
Results from a recent analysis [5] indicated that on the
Affymetrix GeneChip U95A/Av2 array, 20,696 (10.5%)
probes were nonspecific, which could cross-hybridize to
multiple genes, and 18,363 (9.3%) probes missed the tar-
get transcript sequences. The numbers of nonspecific and
mis-targeted probes on the U133A array were comparable,
which were 29,405 (12.1%) and 19,717 (8.0%), respec-
tively [5]. These ~20% of problematic probes certainly
and substantially compromise the data accuracy, decrease
the value of microarray data, and are not acceptable for
the studies of molecular network integration. It was also
found that some probe sets representing the same genes
on Affymetrix microarrays could show significant discrep-
ancy because of the non-specific hybridization [6,7]
In most applications, gene expression profiling with
microarrays including GeneChip requires amplification
of sample RNA, regardless of how much material is avail-
able. Normally, 1 to 3 μg of RNA is required for each assay
[8]. However, high-throughput gene expression profiling
with superior sensitivity is becoming more and more
demanded, and has its wide applications. For example, in
breast cancer research, analysis of specimens from micro-
dissection may provide important information about
genes involved in different cancer development stages and
for understanding the molecular mechanisms underlying
cancer development [9]. Specimens from fine needle
biopsy are also important in diagnostic procedures and in
evaluating therapeutic effects. The ability to analyze a
large number of genes in single cells may help understand
the origin and clonality of cancer development and learn
the molecular details involved in different stages of the
cell cycle.
Current methodologies for gene expression profiling in
small RNA samples, especially those from single cells, are
very limited. Many of these protocols [2,10,11] require
multiple enzymatic reactions that may seriously reduce
the sensitivity and compromise the specificity. RNA prep-
aration in most of applications also involves a number of
steps, which is rather lengthy, tedious, and requires highly
skilled personnel.
To solve the above problems, we have developed a highly
specific and sensitive gene expression profiling system.
With this system, primers are specially designed to
amplify mRNA sequences very specifically. Probes used
for microarray detection are designed only to hybridize to
sequences amplified from mRNA. In conjunction with the
high-throughput multiplex amplification protocol devel-
oped in our laboratory lately [12], a large number of
mRNA species directly released from very few cells or even
single cells can be amplified to a detectable amount with-
out RNA isolation. Amplified products can then be
detected by the single-base extension[13] assay on an oli-
gonucleotide microarray [14].
Results
Experimental system used in the study
To establish a cancer gene expression array, a panel of can-
cer-related genes were selected based on their known
functions and/or cancer-associated expression patterns
from published literature [15-28]. All amplicon sequences
were subjected to computational screening to ensure their
uniqueness. Primers and probes were selected according
to a series of criteria as specified in Materials and Meth-
ods. Most primer pairs amplify sequences in two neigh-
boring exons separated by large introns. The intron
lengths ranged from 79 bp to 90 kb with an average of 2.0
kb and 97% of the introns are longer than 200 bp. Initially
1,445 genes were used as the input for the primer and
probe design program. Primers and probes were selected
for 1,120 (77.5%) of these genes. The remaining 22.5%
had either no introns or no suitable sequences for primers
and/or probes. Fifteen of these remaining genes with
important functions in cancer development were
included in the panel. Primers and probes were designed
based on the unique sequences in these genes, and were
not required to have introns internally located within the
amplified sequences. Therefore, a total of 1,135 genesBMC Genomics 2008, 9:9 http://www.biomedcentral.com/1471-2164/9/9
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were included in our multiplex assay. (Details about these
genes, and their corresponding primers and probes used
for the study are listed in Additional files 1 and 2.)
Microarray-based single-base extension (SBE) assay has
been used to genotype single nucleotide polymorphisms
(SNPs) [12,29,30] in our laboratory. In the present study,
SBE was adapted for gene expression profiling. To sim-
plify the analysis, all probes were designed to terminate
immediately before a 'G' base in the templates. In this
way, the probes were extended by a single base, dideoxy-
nucleoside triphosphate (ddCTP) that was fluorescently
labeled. By using one color, the bias associated with dif-
ferent dyes was also eliminated. The detection procedure
is schematically illustrated in Fig. 1. Resulting data have
been deposited to the NCBI's Gene Expression Omnibus
(GEO) [31] and are accessible through GEO Series acces-
sion number GSE5920.
Reproducibility of the high-throughput gene expression 
profiling system
To test the reproducibility of our system, gene expression
was profiled for three duplicated 100-cell samples from
an ovarian cancer cell line, NCI/ADR-RES [32] and two
100-cell samples from a breast cancer cell line, MCF-7.
Resulting microarray data are supplied in Additional file
3. Table 1 summarizes the numbers of gene transcripts
detected from different samples. As shown, 660 (58.2%),
663 (58.4%), and 662 (58.3%) gene transcripts were
detected from the three 100-cell samples of NCI/ADR-
RES, respectively. Of these transcripts, 650 (>98%) were
detected from all three duplicates. Signal intensities for
the 1,135 genes were strongly correlated between the
duplicates (Pearson's r = 0.977, 0.974, and 0.949, respec-
tively). Fig. 2A shows a scatter plot of two duplicates. Of
the 650 transcripts detected in all three NCI/ADR-RES
100-cell samples, only 6 (0.9%), 17 (2.6%), and 1 (0.2%)
transcripts had their signal intensities differing by >2 fold
between each two of these three duplicates. Twenty-six
transcripts were detected from only one or two of the three
samples. The signal intensities for these transcripts were
low. Only one transcript in one sample had its signal
intensity >1,000, indicating that the inconsistence among
the duplicates was due to low signals of these transcripts.
For the two 100-cell samples from MCF-7, 615 (54.2%)
and 614 (54.1%) gene transcripts were detected, respec-
tively, with 597 (>97%) detected in both. Of these 597
transcripts, 562 (94.1%) had signal intensities differing
less than two fold. Similar to the situation with NCI/ADR-
Schematic illustration of the high-throughput gene expression profiling procedure Figure 1
Schematic illustration of the high-throughput gene expression profiling procedure. Fluorescent labeling is indicated 
by an asterisk.
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RES samples, all 34 transcripts that were detected in only
one sample but not the other had low signal intensities
with only nine genes whose signal intensities were >1,000
in one of the two samples.
Because samples prepared from a large number of cells are
usually associated with high reliability, we further com-
pared the microarray results of the NCI/ADR-RES 100-cell
samples with those from a 10,000-cell sample of the same
cell line. Resulting data also show a high degree of corre-
lation (r = 0.961, Figure 2B). As shown in Table 1, 630
(96.7%) of the 650 gene transcripts detected from all the
100-cell samples were also detected from the 10,000-cell
sample. Sixty-three gene transcripts were detected in at
least one of the three 100-cell samples but not in the
10,000-cell sample, or vice versa. Of these 63 gene tran-
scripts, 61 had signal intensities below 1,000 in all the
three 100-cells. However, the change from 100 to 10,000
cells did enhance the detection of 21 gene transcripts
whose signal intensities were >2 fold greater in the
10,000-cell sample than those in the 100-cell samples.
Among these 21 transcripts, six had signal intensities in
Table 1: Detection of the 1,135 gene transcripts in various samples
Cell Line ADR* MCF-7
Single-Cell 100-Cell 10,000-Cell 100-Cell
Sample I II III I II III I II
Detectable 590 576 614 660 663 662 655 615 614
Undetectable 545 559 521 475 472 473 480 520 521
Detectable in all 504 650 597
Detectable in some 182 26 35
Undetectable in all 449 459 503
Detectable in all 630
Detectable in some 63
Undetectable in all 442
Detectable in all 531
Detectable in some 212
Undetectable in all 392
All ADR*, not MCF-7 75
Both MCF-7, not ADR* 43
Detectable in all 463
Detectable in some 315
Undetectable in all 357
Detectable in all non-single, not in single 61
Detectable in all single, not in non-single 27
*ADR: NCI/ADR-RESBMC Genomics 2008, 9:9 http://www.biomedcentral.com/1471-2164/9/9
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the 10,000-cell sample more than 15 fold greater than the
average intensities of the corresponding genes in the three
100-cell samples, indicating that using 10,000 cells may
have significantly increased the copy numbers of these
transcripts or changed their absence status to presence.
These data indicate that our system not only can produce
very reliable results even with as few as 100 cells but also
is very sensitive to the copy number change for the low-
copy-number gene transcripts.
Sensitivity of the high-throughput gene expression 
profiling system
To further test the sensitivity of our high-throughput gene
expression profiling system, single NCI/ADR-RES cell
samples were prepared and used for multiplex gene
expression assay of the 1,135 mRNA species. Microarray
results from three of these samples are listed in Additional
file 3. The numbers of gene transcripts detected from the
three single-cell samples were 590, 576, and 614, respec-
tively. Of these transcripts, 503 were detected from all sin-
gle cells. Of the 503, 463 (92.0%) were also detected from
all non-single-cell (100-cell and 10,000-cell) samples,
indicating a prevalent expression of these genes in most, if
not all, cells at relatively high levels.
On the other hand, the detection range of gene transcripts
from the three single-cell samples was wider compared to
the non-single-cell samples. As shown in Table 1, 449
transcripts were undetectable in all three single cell sam-
ples, a number which is not greater than that (459) for the
three 100-cell samples and is comparable to that (442) for
all non-single-cell samples. The number of undetectable
gene transcripts from all single and non-single cell sam-
ples is 357. This number means that from single cells, we
not only detected a comparable number of genes, but also
detected a new set of 449-357 = 92 genes that could not
be detected with non-single-cell samples of the same cell
line.
The robustness of gene expression profiling with single-
cell samples was also demonstrated by the signal intensi-
ties. As described above, most transcripts that were
detected from some but not all non-single-cell samples
had low signal intensities and very few were >1,000. The
scenario with single cells is very different. Of the 503 gene
transcripts detected from all single cells, 40 were detected
in one to three non-single-cell samples but not all four. All
40 but one have signal intensity >1,000 in at least one of
the three single-cell samples. Of the 183 transcripts that
were only detected from one or two single-cell samples,
108 (59.0%) had signal intensity >1,000. The strong and
robust signal intensities detected from single-cell samples
indicate that our system is very sensitive.
Unlike the gene transcripts detected from all non-single-
cell samples which account for more than 95% of gene
transcripts detected from each of these samples, the 503
gene transcripts detected from single cells only account for
85. 3%, 87.3% and 81.9% of the transcripts detected from
individual single-cell samples, respectively. Pairwise com-
parison of the results from the single-cell samples yielded
correlation coefficients of 0.780, 0.700, and 0.711, respec-
Comparison of microarray results between duplicated samples Figure 2
Comparison of microarray results between duplicated samples. A. A scatter plot of the microarray intensities of a 
sample with 100 NCI/ADR-RES cells were plotted against those of a duplicated 100-cell sample, and B, a scatter plot in A after 
replacing the data of the latter 100-cell sample with data of a 10,000-cell sample from the same cell line. Microarray intensities 
shown in the figure are the results after baseline subtraction. Both plots are on the log scale.
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tively, compared with = 0.949 for the non-single-cell sam-
ples. From all single and non-single-cell samples, 778
gene transcripts were detected, of which 315 (40.5%)
were detected from some but not all samples. This is in
contrast with the scenario of non-single-cell samples from
which gene transcripts that were only detected from some
but not all samples were a very small portion (Table 1).
Furthermore, of these 315 transcripts, 177 (56.2%) were
either detected from only single cells or from non-single
cell samples.
The high degree of concordance among the results from
the non-single-cell samples, and the significant differ-
ences among those from single cells, and between single
cells and non-single-cell samples indicate that most, if not
all, of these differences are real. As mentioned above, this
is further supported by the robustness of the signal inten-
sities detected from single-cell samples for the gene tran-
scripts that were detected differently between the single
cells and non-single-cell samples. It is conceivable that
heterogeneity in clonality and/or genetic alterations in the
cells of a cell line could be major factors contributing to
the differences. In addition, a considerable portion of the
cells may be at different cycle stages during which groups
of genes are expressed differently. Therefore, while gene
expression in single cells could differ in various aspects,
100 cells may well represent the entire cell population
because, after all, the cell line cells are from the same tis-
sue and the same donor. Therefore, genes that are detect-
able in a cell population may not be expressed or
expressed at very low levels in certain single cells. Con-
versely, genes that are detectable in particular single cell
samples may not be expressed or expressed at very low lev-
els in the majority of the cell population.
Differential gene expression in the two cell lines, NCI/
ADR-RES and MCF-7
When the gene expression profiles of NCI/ADR-RES were
compared with those of MCF-7, a considerable number of
genes were shown to be expressed differentially in these
two cell lines. Of the 1,135 gene products, 531 (46.8%)
were detected from samples of both cell lines (not includ-
ing single cell samples). Seventy-five gene transcripts were
detected in all NCI/ADR-RES non-single-cell samples, but
not in the MCF-7 samples, and 43 were detected in the
opposite way.
Of the 118 differentially expressed genes, 69 were shown
to be expressed with more than 10-fold difference (Table
2). Of the 69 genes, 37 (53.6%) were detected as strongly
or relatively strongly expressed in MCF-7, but weakly or
not expressed in NCI/ADR-RES, and 32 were detected in
the opposite way. To validate the gene expression data, 22
of these 69 genes, and another 46 gene transcripts
detected with various microarray signal intensities differ-
ent between the samples of the two cell lines were ran-
domly selected (Table 3) and subjected to RT-PCR
amplification individually. The amplified products were
resolved by gel electrophoresis. The signal intensities of
the respective bands were quantified with a gel documen-
tation system. Part of results from microarrays and gel
assays are shown in Fig. 3.
Table 3 summarizes the results from both microarray and
gel assays. Based on the results from microarray, genes in
Table 3 are subdivided into four groups. Transcripts of
Group I genes were detected from all samples, while no
transcripts were detectable from all samples for Group IV.
Transcripts of Group III genes were detected only from the
NCI/ADR-RES samples but not from the MCF-7 samples,
and those of Group II genes were detected in an opposite
way. As shown, the signal ratios between NCI/ADR-RES
and MCF-7 from microarray for the Group I genes are well
in concordance with the ratios from gel assay, with a cor-
relation coefficient of 0.679, indicating results from
microarray and gel assays match very well. Because signals
of genes in Groups II to IV were below the background for
at least one of the two cell lines, ratio comparison may not
be meaningful. However, it is clear that the microarray sig-
nals detected from MCF-7 are all greater than those from
NCI/ADR-RES for the Group II genes, and vice versa for
the Group III genes. Results from the gel assay are very
well in concordance with this correlation. The only excep-
tion is HDAC5 whose microarray signal from MCF-7 is
approximately 5 times that from NCI/ADR-RES, while its
gel signal is more than 2 times that of the latter. Since the
microarray signal intensity from MCF-7 for this gene is the
lowest among the Group II genes, this discrepancy could
be caused by wider variation of the low signal intensity.
For all genes in Groups II to IV, if the microarray signals
are lower than background, the corresponding gel signals
are also low (<5,000) except for three genes, HDAC5 in
Group II, and DAB2 and CTSZ in Group III. The fact that
low or relatively low signals were detected by the gel assay
for the genes whose array signals were weaker than back-
ground may be a reflection of the difference between the
two assays. For microarray, all 1,135 transcripts were
amplified in the same tube, while all transcripts analyzed
by gel assay were amplified individually. It is known that
during PCR, after the reaction reaches a saturation point,
very little additional products may be generated. When
the gene transcripts are amplified in a multiplex way, cer-
tain low-copy-number sequences may not be amplified to
the detectable amounts when the reaction reaches a satu-
ration point.
Specificity of the high-throughput gene expression system
The specificity of our high-throughput gene expression
system was demonstrated by the results from different cell
line samples and by those from different single cells asBMC Genomics 2008, 9:9 http://www.biomedcentral.com/1471-2164/9/9
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Table 2: Differentially expressed genes in the two cell lines, MCF-7 and NCI/ADR-RES
Category Gene Ref# Probe ID Gene Symbol Log2 Ratio (NCI/ADR-RES:MCF-7)
Overexpressed genes in NCI/ADR-RES NM_004126 BYH0575 GNG11 6.69
NM_004355 BYH0596 CD74 6.38
NM_005822 BYH0767 DSCR1L1 6.20
NM_005238 BYH0702 ETS1 6.06
NM_002019 BYH0339 FLT1 5.99
NM_000110 BYH0058 DPYD 5.81
NM_001792 BYH0302 CDH2 5.65
NM_001336 BYH0239 CTSZ 5.63
NM_024423 BYH1071 DSC3 5.60
NM_001250 BYH0223 CD40 5.51
NM_001511 BYH0257 CXCL1 5.36
NM_000873 BYH0185 ICAM2 5.32
NM_032727 BYH1080 INA 5.09
NM_005465 BYH0738 AKT3 4.98
NM_003118 BYH0466 SPARC 4.94
NM_001561 BYH0267 TNFRSF9 4.91
NM_000576 BYH0143 IL1B 4.62
NM_003644 BYH0527 GAS7 4.62
NM_001953 BYH0328 ECGF1 4.62
NM_001839 BYH0312 CNN3 4.57
NM_033293 BYH1093 CASP1 4.47
NM_015873 BYH0979 VILL 4.47
NM_057162 BYH1100 KLHL4 4.39
NM_021913 BYH1052 AXL 4.33
NM_000700 BYH0168 ANXA1 4.23
NM_000584 BYH0145 IL8 4.18
NM_000088 BYH0052 COL1A1 4.10
U28727 BYH1107 PAPPA 4.00
NM_001150 BYH0210 ANPEP 3.62
NM_003659 BYH0530 AGPS 3.61
NM_006097 BYH0797 MYL9 3.43
NM_012449 BYH0928 STEAP1 3.35
Underexpressed Genes in NCI/ADR-RES NM_001789 BYH0300 CDC25A -3.34
NM_014427 BYH0960 CPNE7 -3.38
NM_004708 BYH0646 PDCD5 -3.53
NM_005235 BYH0700 ERBB4 -3.63
NM_001702 BYH0281 BAI1 -3.68
NM_005568 BYH0743 LHX1 -3.70
NM_005994 BYH0787 TBX2 -3.78
NM_033016 BYH1086 PDGFB -3.83
NM_001759 BYH0291 CCND2 -3.89
NM_006180 BYH0803 NTRK2 -3.90
NM_000090 BYH0054 COL3A1 -4.00
NM_002051 BYH0343 GATA3 -4.18
NM_001422 BYH0247 ELF5 -4.24
NM_000429 BYH0117 MAT1A -4.32
NM_000633 BYH0158 BCL2 -4.57
NM_000949 BYH0193 PRLR -4.59
NM_014333 BYH0955 CADM1 -4.79
NM_002555 BYH0402 SLC22A18 -5.00
NM_003722 BYH0533 TP73L -5.01
NM_021111 BYH1039 RB1 -5.09
NM_012116 BYH0906 CBLC -5.15
NM_000550 BYH0139 TYRP1 -5.17
AF055033 BYH0006 IGFBP5 -5.52
X52599 BYH1117 NGFB -5.53
NM_000027 BYH0029 AGA -5.54
M35410 BYH0025 IGFBP2 -5.59
NM_003486 BYH0521 SLC7A5 -5.75
NM_018684 BYH1015 KIAA1166 -6.08
NM_000362 BYH0102 TIMP3 -6.14
NM_004378 BYH0600 CRABP1 -6.79
NM_005410 BYH0726 SEPP1 -6.79
NM_001719 BYH0284 BMP7 -6.83
NM_003282 BYH0499 TNNI2 -7.06
NM_004048 BYH0570 B2M -7.07
NM_003177 BYH0473 SYK -7.18
NM_004561 BYH0622 OVOL1 -7.20
NM_000609 BYH0154 CXCL12 -8.3BMC Genomics 2008, 9:9 http://www.biomedcentral.com/1471-2164/9/9
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Table 3: Comparison between the results from microarray and gel assay*
Microarray Intensity Gel Assay Intensity Ratio ADR/MCF-7
Gene Group Gene Symbol ADR MCF-7 ADR MCF-7 Micro-array Gel Assay
I BAI1 1,192 12,372 4,578 1,320 0.10 3.47
SSTR2 9,206 19,108 2,887 7,684 0.48 0.38
MCL1 17,027 31,012 7,481 8,901 0.55 0.84
TPM2 8,582 14,489 34,703 13,186 0.59 2.63
ACOX1 8,125 13,350 26,206 19,508 0.61 1.34
MGAT4B 2,274 3,219 1,053 922 0.71 1.14
UBQLN1 27,113 38,083 24,037 20,089 0.71 1.20
RAB3B 28,188 31,908 33,571 31,044 0.88 1.08
DNMT1 25,315 27,675 41,164 43,718 0.91 0.94
BUB1B 13,233 14,452 21,197 14,321 0.92 1.48
PRDM10 13,233 14,452 9,419 6,641 0.92 1.42
NOTCH3 7,187 7,618 26,090 24,176 0.94 1.08
YY1 27,020 27,930 40,692 33,876 0.97 1.20
TPR 13,081 13,176 32,959 26,423 0.99 1.25
PTTG1IP 12,506 12,298 15,621 12,424 1.02 1.26
PPP2R4 16,105 15,740 15,593 19,497 1.02 0.80
YES1 21,006 20,434 18,228 14,830 1.03 1.23
ZNF670 23,207 22,487 6,581 6,904 1.03 0.95
RAP1GDS1 16,806 15,385 32,743 22,443 1.09 1.46
CKS2 21,507 19,672 10,614 9,289 1.09 1.14
HDAC3 26,309 22,572 28,826 29,169 1.17 0.99
GAPDH 9,369 7,916 34,584 33,939 1.18 1.02
PTTG1 12,802 10,790 18,680 16,447 1.19 1.14
HSPA5 19,233 16,146 17,077 15,423 1.19 1.11
ACTB 6,849 4,400 35,335 35,859 1.56 0.99
ASPH 10,942 4,035 20,194 3,502 2.71 5.77
S100A2 3,498 1,057 13,688 9,559 3.31 1.43
TFG 13,571 3,915 14,015 15,954 3.47 0.88
EGFR 6,841 1,676 34,449 7,738 4.08 4.45
RELA 8,209 1,970 20,099 12,783 4.17 1.57
VIM 12,172 2,192 48,836 2,518 5.55 19.39
RTN1 8,770 1,133 17,159 2,008 7.74 8.55
II CRABP1 94 8,594 0 21,529 0.01 0.00
BMP7 92 8,825 0 43,366 0.01 0.00
TIMP3 92 5,428 0 17,135 0.02 0.00
AGA 90 3,457 0 20,178 0.03 0.00
CXCL12 97 24,456 28 16,471 0.00 0.00
B2M 98 10,621 990 13,599 0.01 0.07
TYRP1 181 5,380 2,125 7,089 0.03 0.30
PDGFB 352 4,080 2,460 6,627 0.09 0.37
GATA3 176 2,618 2,780 4,343 0.07 0.64
SEPP1 84 7,626 3,056 4,432 0.01 0.69
TBX2 202 2,255 4,808 9,482 0.09 0.51
HDAC5 243 1,266 16,605 7,834 0.19 2.12
III ETS1 22,413 280 40,334 0.00 79.97 -
SPARC 9,959 266 44,142 0.00 37.45 -
DSC3 18,136 304 8,076 0.00 59.62 -
CD40 17,887 319 15,499 0.00 56.04 -
FLT1 16,379 209 4,032 371 78.23 10.87
INA 18,499 438 7,908 411 42.27 19.23
CASP1 8,146 298 17,307 447 27.34 38.72
CDH2 12,318 200 10,259 477 61.58 21.53
GNG11 26,835 213 21,000 576 126.28 36.49
MYL9 4,007 302 27,023 1,017 13.26 26.57
CITED1 996 253 9,542 2,606 3.93 3.66
DAB2 1,568 297 32,458 5,136 5.28 6.32
CTSZ 12,657 211 22,322 17,993 59.87 1.24
IV GNRHR 92 214 27 0.00 0.43 -
STK32B 82 208 0.00 241 0.39 0.00
IL13 82 191 0.00 464 0.43 0.00
CDH5 88 213 0.00 519 0.41 0.00
IL3 95 203 86 162 0.47 0.53BMC Genomics 2008, 9:9 http://www.biomedcentral.com/1471-2164/9/9
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described above. To further demonstrate the specificity of
our system, human genomic DNA samples were ampli-
fied with the same multiplex RT-PCR procedure and ana-
lyzed by microarray. Very few probes (<0.2%) were shown
to have signals above background (data not shown), indi-
cating that our system is very specific and can discriminate
between the target mRNA sequences from their genomic
counterparts, and therefore, the unprocessed transcripts.
Our previous experience also showed that in the absence
of specific templates, a few primer sets may amplify non-
specific sequences. However, such non-specific amplifica-
tion may become undetectable in the presence of specific
templates because the specific sequences are much
stronger in competition. In addition, using specially
designed probes also enhanced the specificity.
Discussion
Compared with other existing gene expression profiling
methods, our approach has the following advantages:
(1) Highly specific
To date, no other high-throughput system has been
reported to be highly discriminative of mRNA from other
related DNA and RNA sequences. Using primers amplify-
ing sequences across intron(s) and probes consisting of
sequences in adjacent exons is a critical enhancement to
achieve such high specificity. Furthermore, all primer,
probe and amplicon sequences were subjected to exhaus-
tive searches against the databases of the entire human
genome and transcriptome to ensure these sequences are
unique. Such a step was proven very effective for enhanc-
ing the specificity [12]. Experimentally, when genomic
DNA was used as samples, signals were only detected for
only 2 or 3 genes (0.2%) out of the 1,135 genes. Based on
our previous studies, these signals may become undetect-
able in the presence of specific sequences which may com-
pete out the nonspecific amplification.
(2) Highly sensitive
We showed previously that our multiplex amplification
system could detect >1,000 single-copy sequences simul-
taneously from single haploid sperm cells [12]. The fact
that >90% of these sequences are detectable indicates that
with our specially designed primers, most, if not all,
sequences may be well amplified parallelly with very lim-
ited, if any, interaction among the primers. Since the
primers used for gene profiling are designed in the same
way, it is reasonable to believe that most gene transcripts
are also amplified parallelly. However, since the copy
number of different gene transcripts in the cells varies in a
wide range, the outcome of amplification would be differ-
Differential gene expression in the two cell lines, MCF-7 and  NCI/ADR-RES Figure 3
Differential gene expression in the two cell lines, 
MCF-7 and NCI/ADR-RES. Upper, Microarray images 
from the two cell lines. Lower, confirmation of the gene 
expression profiling results by gel assay. Quantitative results 
are given in Table 3. M, MCF-7, and A, NCI/ADR-RES.
MCF-7 NCI/ADR-RES
M    A     M    A     M   A     M     A    M    A     M    A
AGA     TIMP3   DNMT1    BMP7  SPARC    VIM
HDAC3   EGFR     ETS1   MMP11   ACTB    GAPDH
M   A     M    A    M     A    M     A    M    A     M    A
NOTCH3  DAB2  MGAT4B PAPPA CRABP1  RAB3B
M   A     M    A    M     A    M     A    M    A     M    A
LYL1 85 218 128 64 0.39 2.01
CA1 87 192 365 95 0.45 3.83
TYROBP 91 199 487 169 0.46 2.89
IL13RA2 87 187 1,771 433 0.47 4.09
IRF8 86 212 3,695 571 0.41 6.47
MMP11 145 234 3,060 2,308 0.62 1.33
Note: 1. Signal intensities of microarray are averages of those respective non-single cell samples. 2. ADR: NCI/ADR-RES.
Table 3: Comparison between the results from microarray and gel assay* (Continued)BMC Genomics 2008, 9:9 http://www.biomedcentral.com/1471-2164/9/9
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ent from that using single-copy sequences. When only sin-
gle-copy sequences are used in multiplex amplification,
most, if not all, sequences may reach the detectable
amount before the system is saturated. However, when
gene transcripts are amplified, whether a transcript
reaches a detectable amount before the system is saturated
depends on its copy number in the sample, and not all
sequences may reach a detectable amount at the end of
amplification. This is probably why some sequences were
undetectable by microarray but detectable by gel assay.
With our system, a total of 686 gene transcripts were
detected from three single cells, which is comparable to
676 for the three 100-cell samples and 693 for all non-sin-
gle-cell samples from the same cell line. The sensitivity of
our system is further proved by the facts that results from
100-cell samples are very similar to each other and to
those from 10,000 cells, and that specific gene expression
profiles were obtained from different cell lines using as
few as 100 cells.
The sensitivity of our system is further illustrated by the
results that a significant portion of transcripts that could
not be detected from the NCI/ADR-RES samples but were
detected from the MCF-7 samples or single cell samples,
and  vice versa. This also indicates that low microarray
intensities for these transcripts were not false negatives,
and they were either not present or present in very low
abundance in the respective samples.
(3) Very simple
Unlike other methods that involve multiple steps and use
multiple enzymes, our method allows a large number of
gene products amplified by a single RT-PCR step directly
from cell lysates without RNA extraction. In this way, a
large number of samples may be analyzed easily and cost-
effectively. Our simple experimental procedure is also the
basis of the high degree of sensitivity since it avoids com-
plicated mRNA extraction and processing procedures
before and during amplification, which may cause mRNA
degradation or loss.
(4) Very safe for RNA samples
When working with RNA, one has to take extra precaution
to prevent mRNA from degradation. Our method does
not need RNA extraction. Once cells are lysed, RNA is
directly released to the RT-PCR buffer and used as tem-
plate immediately. There is almost no chance for RNase to
degrade the mRNA templates.
(5) Highly flexible
Many studies may not need to analyze all genes in the
human genome and may often need to focus on different
gene groups. Therefore, flexibility of the experimental sys-
tem would be highly desirable. With our computer pro-
gram, a large number of gene products can be designed
into a single multiplex group. Genes can be easily organ-
ized into different subgroups upon need, and can also be
re-grouped at any time without altering the reaction con-
ditions. New gene products can be added to an existing set
easily.
The capacity of multiplex RT-PCR is another concern for
high-throughput gene expression profiling because it not
only makes the amplification of a large number of gene
products affordable and cost-effective, but also eliminates
challenges involved in quality control of RT-PCR for a
large number of genes individually [33,34]. However, the
capacity of multiplex amplification was limited by inter-
action between primers. A previous study reported a
screening of 29 expressed genes using multiplex RT-PCR,
but was unable to reduce the number of the reaction tubes
less than eight [35]. Other studies multiplexed up to nine
genes with nonspecific RT primers [36,37]. Studies using
multiple sets of gene-specific primers in single reactions
were also reported, but none of these generated enough
products for the analysis of all expressed genes in the sam-
ples [34,38]. In the present study, we report our success
with multiplex RT-PCR for 1,135 mRNA species. Such a
success was based on a combination of several technolog-
ical developments, including computerized primer design
with predicted minimal interaction, a narrow primer Tm
range, small amplicon sizes, and optimization of amplifi-
cation conditions based on our previous experience
[12,29,30]. With our current protocol, it is possible to
include two thousand or more gene transcripts in a single
multiplex amplification group, and to analyze all human
gene transcripts using several multiplexing amplification
groups. After pooling amplified products from the multi-
plexing groups, all genes may be analyzed with a single
microarray. With our system, large-scale gene expression
profiling becomes highly affordable and cost-effective. If
the primers and probes used in the high-throughput anal-
ysis are made accessible to the research community
through a distribution system, large- and genome-scale
gene expression profiling may be even more affordable
and cost-effective.
A major limitation of our system is the requirement of
presence of large introns in genes under study. When the
introns are small, discrimination between mRNA and
closely related DNA and RNA sequences is still possible by
using probes consisting of sequences in the neighboring
exons. For genes with no introns, primers and probes can
be designed only to discriminate mRNA sequences from
related pseudogenes and their transcripts but not the cor-
responding gene sequences. In this case, discrimination
between mRNAs and their gene sequences is only possible
when the mRNAs are present abundantly.BMC Genomics 2008, 9:9 http://www.biomedcentral.com/1471-2164/9/9
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An extreme and possible application of our highly sensi-
tive gene expression profiling system is the analysis of dis-
seminated tumor cells in cancer research. Analysis of
individual cells is necessary for understanding the early
dissemination of tumor cells. Disseminated tumor cells
remain in the patient bodies even after complete resection
of the primary tumor, and can be obtained by bone mar-
row aspirates [39]. With our highly sensitive system,
genetic signature in these cells may be detected. The result-
ing information may provide molecular basis for new
therapeutic targets. For example, ERBB2 expression has
been found to be a therapeutic target for metastatic breast
carcinoma [40]. Identification of mRNA like that of
ERBB2 in micrometastatic cells may help develop effective
therapeutical approaches to preventing further develop-
ment of these cells into incurable metastasis. Using mRNA
from a small number of microdissected frozen tissue sec-
tions without RNA isolation has been demonstrated with
a small number of genes [41]. Our system should be capa-
ble of using both microdissected and biopsy specimens
for gene expression analysis on a much larger scale.
High-throughput gene expression profiling with single
cells is also interesting for most laboratories studying
molecular neurophysiology, but has been hampered by
the capacity of multiplex PCR. Our approach can be used
to examine the expression of many genes within individ-
ual neurons or other cells. The gene expression profiles
can also be correlated to the phenotypes of these cells
such as morphological, electrophysiological and pharma-
cological features to understand the underlying molecular
mechanisms.
Conclusion
This report describes a high-throughput gene expression
profiling technology, which is simple, highly reproduci-
ble, specific and sensitive, and may greatly facilitate gene
expression profiling of a small number of or even single
cells. It may also be applicable to many applications
where the amount of material is limited, and to diagnostic
assays that identify the onset of cancer and monitor its
progression, remediation or response to treatments.
Data discussed in this publication have been deposited in
the NCBI's Gene Expression Omnibus [31] and are acces-
sible through GEO Series accession number GSE5920.
Methods
Cell lines and single cell preparation
Human breast cancer cell line MCF-7 and ovarian cancer
cell line NCI/ADR-RES were kindly provided by Drs. Jin-
ming Yang, Hao Wu and William Hait [42]. The cell lines
were maintained in RPMI 1640 medium containing 10%
fetal bovine serum, 100 units/ml penicillin, and 100 μg/
ml streptomycin at 37°C in a humidified atmosphere
containing 5% CO2. After counting with a hemacytome-
ter, cells were suspended in PBS (phosphate buffer solu-
tion) to 1000 cells/μl or other desirable densities. Two μl
was dispensed into an Eppendorf tube containing cell
lysis buffer (1.5 μl RNase inhibitor, 4 μl of 5× QIAGEN
OneStep RT-PCR buffer, 12.5 μl H2O). Single cells were
prepared from a diluted cell suspension of 2 cells/μl in 1
× PBS. About 0.5 μl of the suspension was pipetted onto a
small piece of glass coverslip, and was checked under a
microscope. If the droplet contained only one cell, the
piece of the coverslip was then transferred into an Eppen-
dorf tube containing the cell lysis buffer. The tube was
immediately frozen in an ethanol/dry ice bath and stored
at -80°C until use.
Selection of genes for mRNA profiling
Genes used in the present study were selected based on
previous publications [15-28], and are those involved in
fundamental cell functions such as cell cycle, apoptosis,
cell matrix, DNA repair, DNA replication, somatic recom-
bination, RNA transcription and regulation, and protein
translation and regulation. The borders between exons
and introns for the selected genes were determined by
aligning of the mRNA to genomic sequences using the
BLAT program [43] maintained by the University of Cali-
fornia, Santa Cruz.
Primer and probe design
A computer program was written for primer and probe
selection. Each pair of PCR primers was designed to
amplify sequences in two adjacent exons flanking a large
intron and to ensure specific amplification of the desira-
ble mRNA sequences rather than the respective gene or
unprocessed RNA sequences. To enhance the amplifica-
tion specificity, the program always searches for candidate
amplicon sequences separated by large introns in each
gene. The melting temperatures (Tm's) for all selected
primers ranged from 50.1°C to 61.6°C, and the GC-con-
tents ranged from 32% to 70%. The lengths of the ampli-
cons ranged from 72 to 150 bases.
Each oligonucleotide probe for microarray analysis was
designed to consist of sequences of two adjacent exons to
specifically interrogate the cDNA from corresponding
mRNA sequence, but not the corresponding gene
sequences or cDNA from unprocessed RNA. To facilitate
microarray analysis, the 3'-ends of all probes terminated
before a "G" base in the template sequence so that they
can be labeled with the same fluorescent color by incorpo-
rating fluorescently labeled Cy5-ddCTP. The lengths of
the probes ranged from 22 to 31 bases, and the GC-con-
tent of the probes ranged from 30% to 70% with their Tm's
from 54.4°C to 65.2°C.BMC Genomics 2008, 9:9 http://www.biomedcentral.com/1471-2164/9/9
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The BLAST executable program and sequence databases
were downloaded from NCBI website [44] and installed
to a local server. All the primers were subjected to BLAST
search both in the human genome and the transcriptome
databases to avoid amplification of nonspecific genomic
or RNA sequences including pseudogenes and their RNA
products. In addition, all primers and probes were sub-
jected to interaction analysis with a computer program
developed for designing high-throughput multiplex
nucleotide acid detection [12]. Probes complementary to
intron regions of some genes were also designed as nega-
tive controls. All amplicon sequences were subjected to
BLAST search to ensure their uniqueness. Details about
the primer and probe design for the high-throughput mul-
tiplex nucleic acid detection may be found in our previous
publication [12].
Gene-specific reverse transcription and multiplex RT-PCR
Cells in the lysis buffer described above were lysed with
three repeating cycles of alternating one-min incubations
from the ethanol/dry ice mix to a 37°C water bath before
RT-PCR. One-step RT-PCR was carried out in a 50-μl reac-
tion containing primers (20 nM each) for all the 1,135
mRNA species, 2.5 mM MgCl2, the four dNTPs (400 μM
each), and 2.0 μl QIAGEN OneStep RT-PCR Enzyme Mix
without degenerated primers. The samples were first incu-
bated at 50°C for 40 min for cDNA synthesis, and then
were heated to 95°C for 15 min to inactivate the reverse
transcriptase and activate the Taq DNA polymerase fol-
lowed by 45 PCR cycles. Each PCR cycle consisted of 40
sec at 94°C for denaturation, and 1 min at 55°C and 5
min of ramping from 55°C to 70°C for annealing and
extension. A final extension step was carried out at 72°C
for 3 min at the end of the PCR. All PCRs were performed
with the PTC100 Programmable Thermal Controllers (MJ
Research). Single-stranded DNA (ssDNA) was generated
by using the same conditions in multiplex PCR except for
the templates that were 10 μl of the multiplex RT-PCR
product. Only one primer for each sequence was used,
and 40 thermal cycles were carried out.
RT-PCR with individual gene transcripts
RT-PCRs with individual gene transcripts were performed
for a group of genes with different amounts of signal
intensities detected from the two cell lines, NCI/ADR-RES
and MCF-7. For each gene, an aliquot (equivalent of 100
cells) from the same cell lysate used for multiplex gene
expression profiling was used. Conditions for one-step
RT-PCR were similar to those for multiplex one-step RT-
PCR. mRNAs transcribed from β-actin and α-tubulin
genes served as internal controls. The PCR products were
assayed by gel electrophoresis. Gels were imaged using an
Image Station (Model 440, Kodak, New Haven, CT, USA).
Gel band intensities were digitized with the software,
Kodak 1D 3.5.
Microarray design, hybridization, and probe labeling by single-base 
extension assay
Oligonucleotide probes were printed onto glass slides in
duplicate with a spot diameter of 160 μm and a center-to-
center distance of 250 μm by using the OmniGrid Accent
Microarrayer (Gene Machines, CA). One hundred four-
teen spots with only microarray printing buffer without
probes were used as negative controls and were distrib-
uted spatially evenly across each array. Microarray analysis
was performed according to a four-step procedure estab-
lished in our laboratory [12]. Briefly, (1) preparation of
microarray slides: Pre-cleaned Gold Seal Micro slides
(Becton Dickinson) with no scratch were chosen, and
were soaked in 30% bleach with shaking for 1–2 hrs fol-
lowed by rinsing five times with deionized H2O and three
times with MilliQ H2O. Slides were then sonicated in 15%
Fisher brand Versa-Clean Liquid Concentrate with heat on
for 1–2 hrs followed by rinsing with shaking 10 times in
deionized H2O and five times in MilliQ H2O. Slides were
dried by centrifugation at 1,000 rpm for 5 min with a slide
holder in a GS-6 Beckman centrifuge, and then were
baked at 140°C in a vacuum oven for 4–5 hrs (Fisher Sci-
entific Model 280A); (2) microarray preparation: each oli-
gonucleotide probe was mixed with the Microarray
Printing Solution (GenScript, Piscataway NJ) at a 1:5 ratio
(v/v) to a final concentration of 50 μM in a well of a 384-
well plate. Probes were then arrayed onto the washed glass
slides with humidity between 50% and 55%, and temper-
ature between 24.5°C to 26.5°C; (3) hybridization: Each
glass slide with probe arrays was placed into a Corning
slide cassette. Hybridization was performed in 30 μl of 1×
hybridization solution (5× Denhart's solution, 0.5% SDS,
3 × SSC, 20 μl of ssDNA at 56°C for 2 hrs. The cassette was
briefly soaked in iced water before opening. The slide was
then washed with 1 × SSC and 0.1% SDS at 56°C for 10
min, rinsed twice with 0.5 × SSC for 30 sec and twice with
0.2 × SSC for 30 sec; and (4) probe labeling by single base
extension: microarrays consisting of oligonucleotide
probes were covered with 25 μl 1× labeling solution con-
taining 20 units of Sequenase, 1× Sequenase buffer (GE
Healthcare Life Sciences, Piscataway, NJ), and 750 nM
Cy5-ddCTP (Applied Biosystems, Foster City, CA). The
labeling reaction was performed at 70°C for 10 min. The
slide was washed again under the same conditions used
after hybridization.
Microarray scanning and data analysis
Microarrays were scanned with a GenePix 4000 scanner
(Axon Instruments, Foster City, CA). The resultant images
were digitized with the accompanying software Genepix
Pro (version 4.0). The mean values of the signals from the
duplicate spots of each probe were used for the analysis in
Tables 1 and 2. Background signal was determined by
using negative control probes that were complementary to
the intron sequences of the corresponding genes or ran-BMC Genomics 2008, 9:9 http://www.biomedcentral.com/1471-2164/9/9
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dom sequences, and was subtracted from the sample sig-
nals. For the comparative expression analysis of the cell
lines MCF-7 and NCI/ADR-RES in Table 1, the array data
were normalized by the Lowess smoothing method
[45,46]. After background subtraction, genes with nega-
tive values of signal intensities in both duplicated samples
were excluded for further analysis. The log ratios of the
intensities of the remaining genes in two cells lines were
used to make calls and to identify the differentially
expressed genes in the samples.
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